Pulse Biosciences to Redeem Warrants, Triggering $2.1M Cash Inflow
PLSE sits 97% above its 52-week low of $12.56.
Summary
Pulse Biosciences is redeeming its 200% Warrants due to strong stock performance, which is expected to bring in an additional $2.1 million in cash.
Key Events · Financing and Capital Events · PLSE
-
Warrant Redemption Initiated
Pulse Biosciences announced an irrevocable election to redeem its outstanding 200% Warrants, which were issued in July 2024 as part of a rights offering.
-
Stock Price Threshold Met
The redemption was triggered because the company's volume-weighted average stock price exceeded $22.00 for 20 consecutive trading days, with an average VWAP of $25.17 over that period.
-
Cash Inflow Expected
Warrant holders have until July 13, 2026, to exercise their warrants at $11.00 per share. This is expected to generate an additional $2.1 million in gross proceeds for the company.
-
Prior Successful Redemptions
The company previously redeemed its 150% Warrants in February 2025 and has already received $63.7 million from warrant redemptions to date.
Analysis · PLSE · Industrial Applications And Services
Pulse Biosciences is redeeming its outstanding 200% Warrants, a move triggered by its stock price exceeding the $22.00 threshold for 20 consecutive trading days. This action will compel warrant holders to exercise their warrants at $11.00 per share by July 13, 2026, or have them redeemed for $0.01. This is a positive development, as it confirms strong stock performance and is expected to generate an additional $2.1 million in gross proceeds for the company, building on previous successful warrant redemptions.
At the time of this filing, PLSE was trading at $24.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $12.56 to $28.53. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.